MediGene AG · Martinsried Germany (German: MDG)
Key MediGene AG Financials
| Company Type | Public -(German: MDG) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $3.0 |
| 2010 Employees | 92 |
MediGene AG Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 3.0 | 56.6 | 55.8 |
| Cost of Goods Sold | 1.0 | 45.1 | 38.0 |
| Gross Profit | 2.0 | 11.4 | 17.9 |
| Gross Profit Margin | 65.9% | 20.2% | 32% |
| SG&A Expense | 12.5 | 13.1 | 7.0 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | (36.6) | (28.1) | 44.7 |
| Operating Margin | -1203.9% | -49.8% | 80% |
| Nonoperating Income | 0.1 | (3.5) | (93.4) |
| Nonoperating Expenses | 0.5 | 0.2 | 2.0 |
| Income Before Taxes | (36.0) | (31.4) | (46.7) |
| Income Taxes | 0.0 | (3.3) | |
| Net Income After Taxes | (36.0) | (31.5) | (43.4) |
| Continuing Operations | (36.0) | (31.5) | (43.4) |
| Discontinued Operations | 12.3 | -- | -- |
| Total Operations | (23.7) | (31.5) | (43.4) |
| Total Net Income | (23.7) | (31.5) | (43.4) |
| Net Profit Margin | -779.6% | -55.6% | -77.7% |
| Diluted EPS from Total Net Income | (0.65) | (0.92) | (1.28) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
MediGene AG Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 6.3 | 17.6 | 35.4 |
| Net Receivables | -- | -- | -- |
| Inventories | 2.2 | 2.1 | 3.1 |
| Other Current Assets | 15.2 | 10.1 | 12.5 |
| Total Current Assets | 23.8 | 29.8 | 51.0 |
| Net Fixed Assets | 1.3 | 1.5 | 1.6 |
| Other Noncurrent Assets | 52.1 | 62.9 | 61.2 |
| Total Assets | 77.1 | 94.2 | 113.8 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 3.1 | 3.5 | 14.8 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 19.6 | 16.0 | 7.0 |
| Total Current Liabilities | 22.7 | 19.5 | 21.8 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 0.3 | 0.3 | 0.5 |
| Total Liabilities | 23.1 | 19.8 | 22.3 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 54.1 | 74.3 | 91.5 |
| Total Equity | 54.1 | 74.3 | 91.5 |
| Shares Outstanding (thou.) | 37,082.8 | 35,557.5 | 34,028.6 |
All amounts in millions of US Dollars except per share amounts.
MediGene AG Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | (15) | (27) | (39) |
| Net Investing Cash Flow | (0.4) | 0.3 | 6.1 |
| Net Financing Cash Flow | 5.9 | 8.2 | 2.4 |
| Net Change in Cash | (9.6) | (18.6) | (30.0) |
| Depreciation & Amortization | |||
| Capital Expenditures | (0.4) | (0.7) | (0.5) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.